Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study

被引：3

作者：

Unglaub, Julia M.

Schlenk, Richard F.

Hanoun, Maher

Reinhardt, H. Christian

Middeke, Jan Moritz

Schaefer-Eckart, Kerstin

Steffen, Bjoern

Krause, Stefan W.

Schliemann, Christoph

Kaufmann, Martin

Haenel, Mathias

Jost, Edgar

Crysandt, Martina

Fransecky, Lars

Kraus, Sabrina

Einsele, Hermann

Niemann, Dirk

Neubauer, Andreas

Seggewiss-Bernhardt, Ruth

Scholl, Sebastian

Klein, Stefan

Schmid, Christoph

Schaich, Markus

Platzbecker, Uwe

Baldus, Claudia D.

Bornhaeuser, Martin

Serve, Hubert

Rollig, Christoph

Kramer, Michael

Katelari, Elena

Janssen, Maike

Pabst, Caroline

Luft, Thomas

Dreger, Peter

Mueller-Tidow, Carsten

Sauer, Tim

机构：

[1] Univ Hosp Heidelberg, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany

[2] Natl Ctr Tumor Dis, NCT Trial Ctr, German Canc Res Ctr, Heidelberg, Germany

[3] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[4] Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany

[5] Hosp Nurnberg, Dept Internal Med 5, Nurnberg, Germany

[6] Univ Hosp Frankfurt Main, Dept Hematol & Oncol, Frankfurt, Germany

[7] Univ Hosp Erlangen, Dept Hematol & Med Oncol, Erlangen, Germany

[8] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany

[9] Robert Bosch Krankenhaus, Dept Hematol Oncol & Palliat Med, Stuttgart, Germany

[10] Chemnitz Hosp, Dept Internal Med 3, Chemnitz, Germany

[11] Rhein Westfal TH Aachen, Univ Hosp, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany

[12] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[13] Univ Hosp Wuerzburg, Dept Med 2, Wurzburg, Germany

[14] Ev Stift St Martin, Dept Hematol Oncol & Palliat Med, Koblenz, Germany

[15] Univ Hosp Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany

[16] Sozial Stiftung Bamberg, Dept Hematol Oncol, Bamberg, Germany

[17] Univ Hosp Jena, Jena, Germany

[18] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany

[19] Univ Hosp Augsburg, Dept Hematol & Oncol, Augsburg, Germany

[20] Rems Murr Klinikum Winnenden, Dept Hematol Oncol & Palliat Med, Winnenden, Germany

[21] Univ Hosp Leipzig, Leipzig, Germany

[22] Univ Hosp, Dept Internal Med 1, Dresden, Germany

[23] Univ Hosp Heidelberg, Internal Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-151287

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4418

引用

页数：7

共 50 条

[21] Nivolumab salvage therapy before and after allogeneic stem cell transplantation in relapsed/refractory hodgkin lymphoma
Cheikh, J. E. I.
Massoud, R.
Abudalle, I.
Haffar, B.
Mahfouz, R.
Kharfan-Dabaja, M. A.
Jisr, T.
Mougharbel, A.
Ibrahim, A.
Bazarbachi, A.
BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S30
[22] Daratumumab as salvage therapy in relapsed/refractory multiple myeloma patients after allogeneic stem cell transplantation
Essmann, S.
von Pein, U. -M.
Klyuchnikov, E.
Janson, D.
Bonmann, S.
Ayuk, F. A.
Wolschke, C.
Kroeger, N.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 190 - 190
[23] Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study
De Lima, Marcos
Silva, Leandro de Padua
Giralt, Sergio
Komanduri, Krishna
Andersson, Borje S.
Hosing, Chitra
Qazilbash, Muzaffar
Shpall, Elizabeth
Thall, Peter
Zhang, Weiqing
McCormick, Gloria
Wang, Xuemei
Popat, Uday
Soriano, Andres
Alousi, Amin
Champlin, Richard
Garcia-Manero, Guillermo
BLOOD, 2008, 112 (11) : 414 - 414
[24] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
Andrius Zucenka
Vilmante Vaitekenaite
Kazimieras Maneikis
Linas Davainis
Regina Pileckyte
Igoris Trociukas
Valdas Peceliunas
Tadas Zvirblis
Vytautas Staras
Laimonas Griskevicius
Bone Marrow Transplantation, 2021, 56 : 2804 - 2812
[25] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
Zucenka, Andrius
Vaitekenaite, Vilmante
Maneikis, Kazimieras
Davainis, Linas
Pileckyte, Regina
Trociukas, Igoris
Peceliunas, Valdas
Zvirblis, Tadas
Staras, Vytautas
Griskevicius, Laimonas
BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2804 - 2812
[26] DECITABINE IN COMBINATION WITH DONOR LYMPHOCYTE INFUSION AS SALVAGE THERAPY FOR RELAPSED AML POST-ALLOGENEIC STEM CELL TRANSPLANTATION
Kritharis, A.
Donahue, L. L.
Keyzner, A.
Devoe, C.
Bayer, R. L.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S327 - S327
[27] Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis
Zhao, Yanmin
Shi, Jimin
Li, Xiaoqing
Wang, Jiasheng
Sun, Jie
Zhou, Jianfeng
Huang, He
BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 824 - 826
[28] Allogeneic hematopoietic cell transplantation in aplasia after Cladribine/Cytarabine salvage chemotherapy for refractory or relapsed AML and MDS - a single center experience
Vydra, Jan
Markova, Marketa St'astna
Valkova, Veronika
Novakova, Ludmila
Cemusova, Barbora
Soukup, Petr
Kolar, Michal
Vitek, Antonin
Cetkovsky, Petr
BONE MARROW TRANSPLANTATION, 2018, 53 : 147 - 148
[29] Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis
Yanmin Zhao
Jimin Shi
Xiaoqing Li
Jiasheng Wang
Jie Sun
Jianfeng Zhou
He Huang
Bone Marrow Transplantation, 2020, 55 : 824 - 826
[30] - Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability - Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML
Middeke, Jan Moritz
Herbst, Regina
Parmentier, Stefani B.
Bug, Gesine
Haenel, Mathias
Stuhler, Gernot
Schaefer-Eckart, Kerstin
Roesler, Wolf
Klein, Stefan A.
Bethge, Wolfgang
Bitz, Ulrich
Alakel, Nael
Schaich, Markus
Morgner, Anke
Kramer, Michael
Platzbecker, Uwe
Roellig, Christoph
Thiede, Christian
Ehninger, Gerhard
Bornhaeuser, Martin
Schetelig, Johannes
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →